Please login to the form below

Not currently logged in
Email:
Password:

Alexza’s Peter Schineller joins Agendia

Appointed first chief commercial officer

Agendia Peter SchinellerCancer diagnostics firm Agendia has appointed Peter Schineller as its first chief commercial officer.

Schineller's appointment marks a swift departure from his previous role at Alexza Pharmaceuticals, which he only joined in March 2013 as senior VP and chief commercial officer.

He has additional healthcare experience as general manager at Roche subsidiary Ventana Medical Systems and as senior VP for sales, marketing and commercial operations at Genoptix Medical Laboratories, a diagnostic firm that was acquired by Novartis.

David Macdonald, Agendia's CEO, explained the creation of the new commercial role: "As we continue our growth momentum into 2013, we are committed to building out a world class organisation capable of managing and growing a much larger company.

"Mr Schineller's depth of experienced senior leadership of global commercial organisations will help us perpetuate our volume growth, which exceeded 140 percent in 2012."

5th June 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...

Infographics